Dr. Rebecca Feldman on Caveolin-1 and its Potential in Breast Cancer Treatment

Rebecca Feldman, PhD, molecular science liaison/research scientist, Caris Life Sciences, discusses caveolin-1, which has the potential to play a major role in the treatment of breast cancer.

Feldman says that by targeting caveolin-1, medical professionals could potentially restrict the growth of breast cancer in a patient. She adds that by targeting caveolin-1 and restricting breast cancer growth, new treatments that target EGFR and PDGFRA could also become a possibility. This is due to caveolin-1’s role of signaling processes on the molecular level.